Keywords: Androgen; breast cancer; endocrine therapy; endometrial cancer; LHRH; neuroendocrine tumours; oestrogen; prostate cancer;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Castrate-resistant prostate cancer; CRPC; Androgen deprivation therapy; ADT; LHRH; Immune therapy; Skeletal-related event (SRE);
Keywords: ADT; androgen deprivation therapy; AE; adverse event; CRPC; castration-resistant prostate cancer; LHRH; luteinizing hormone-releasing hormone; mCRPC; metastatic CRPC; MFS; metastase-free survival; nmCRPC; non-metastatic CRPC; PFS; progression-free surviva
Keywords: ART; Assisted reproductive technologies; BMI; Body mass index; CI; Confidence interval; ET; embryo-transfer; FIVET; Fertilization in-vitro with embryo transfer; FSH; Follicle-stimulating hormone; GIFT; Gametes Intra Fallopian Transfer; GnRH; Gonadotropin-
Keywords: prostatic neoplasms; castration-resistant; surveys and questionnaires; case reports; practice patterns; physicians; ADT; androgen deprivation therapy; CME; continuing medical education; CT; computerized tomography; LHRH; luteinizing hormone-releasing horm
Keywords: MDR; multi-drug resistance; PPI; polypropyleneimine; RBC; red blood cell; WBC; white blood cell; LDH; lactate dehydrogenase; EPR; enhances permeability and retention; FA; folic acid; FR; FA receptor; SMUT; sodium-dependent multi-vitamin transporter; FITC;
Keywords: LHRH; luteinizing hormone releasing hormone; ADT; androgen depletion therapy; CRPC; castration-resistant prostate cancer; CYP17; cytochrome P450 c17; MR; mineralocorticoid receptor; ER; estrogen receptor; PR; progestins receptor; GR; glucocorticoid recept
Keywords: prostatic neoplasms; orchiectomy; testosterone; triptorelin pamoate; castration; male; ADT; androgen deprivation therapy; BMI; body mass index; CV; coefficient of variance; DHEAS; dehydroepiandrosterone sulfate; FSH; follicle-stimulating hormone; LC-MS/MS
Keywords: prostatic neoplasms; testosterone; prostate-specific antigen; leuprolide; mortality; ADT; androgen deprivation therapy; CAD; continuous androgen deprivation; CRPC; castration resistant prostate cancer; CSS; cause specific survival; IAD; intermittent andro
Keywords: antineoplastic agents, hormonal; costs and cost analysis; prostatic neoplasms; neoplasm metastasis; orchiectomy; ADT; androgen deprivation therapy; BSO; bilateral simple orchiectomy; ESO; epididymal sparing orchiectomy; LHRH; luteinizing hormone-releasing
Keywords: LHRH; GnRH; Hormonal therapy; Advanced prostate cancer
Keywords: LHRH; LC/MS; LH release; Bioavailability; Pharmacokinetic;
Keywords: PND; post natal day; C; control group; E; ethanol group; EC; ethanol + vitamin C group; MDA; malondialdehyde; TBARS; thiobarbituric acid reactive species; TBA; thiobarbituric acid; GSH; reduced glutathione; DSP; daily sperm production; HTF; human tubal
Keywords: AuNPs; gold nanoparticles; AuNSs; gold nanoshells; AuNRs; gold nanorods; CTAB; cetyltrimethylammonium bromide; EPR; enhanced permeability and retention; RES; reticuloendothelial system; PEG; polyethylene glycol; NIR; near-infrared; TEM; transmission elect
Keywords: AFM; atomic force microscopy; DFS; dynamic single-molecule force spectroscopy; F-D; force-distance; GPCR; G protein-coupled receptor; HOPG; highly ordered pyrolytic graphite; ICAM-1; intercellular adhesion molecule-1; LFA-1; leukocyte function-associa
Keywords: APC; adenomatous polyposis coli; APE1/Ref; apurinic apyrimidinic endonuclease redox effector factor; APK; activated protein kinase; BTG; B-cell translocation gene; CSC; cancer stem cells; CSF; colony-stimulating factor; DSH; disheveled; ECGF1; endothelial
Keywords: ABC; adenosine triphosphate (ATP)-binding cassette; ASO; antisense oligonucleotides; CPT; camptothecin; DBD; drug-binding domain; DDS; drug delivery system; DOX; doxorubicin; EPR; enhanced permeability and retention effect; IC50 dose; a dose that kills 50
Molecular characterization and expression of Piwil1 and Piwil2 during gonadal development and treatment with HCG and LHRH-A2 in Odontobutis potamophila
Keywords: HPG; hypothalamic-pituitary-gonadal; GnRH; Gonadotropin-releasing hormone; GTH; gonadotropins; FSH; follicle-stimulating hormone; LH; luteinizing hormone; LHRH; luteinizing hormone-releasing hormone; HCG; human chorionic gonadotropin; ORF; open reading
Evolutionary conservation and divergence of Vasa, Dazl and Nanos1 during embryogenesis and gametogenesis in dark sleeper (Odontobutis potamophila)
Keywords: HPG; hypothalamic-pituitary-gonadal; GnRH; Gonadotropin-releasing hormone; GTH; gonadotropins; FSH; follicle-stimulating hormone; LH; luteinizing hormone; LHRH; luteinizing hormone-releasing hormone; HCG; human chorionic gonadotropin; ORF; open reading fr
Mesoporous silica nanoparticles for drug and gene delivery
Keywords: AO; acridine orange; APTES; 3-aminopropyltriethoxysilane; APTMS; amino propyl trimethoxysilane; BCL-2; B-cell lymphoma-2; BCS; Biopharmaceutical Classification System; Bio-TEM; biological transmission electron microscopy; C dots; Cornell dots; CMC; critic
Deficiency in GnRH receptor trafficking due to a novel homozygous mutation causes idiopathic hypogonadotropic hypogonadism in three prepubertal siblings
Keywords: CDGP; constitutional delay of growth and puberty; CHO; Chinese hamster ovary; E2; estradiol; ER; endoplasmic reticulum; FSH; follicle-stimulating hormone; GnRH; gonadotropin-releasing hormone; HEK; human embryonic kidney; H-P-G axis; hypothalamic-pituit
Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin
Keywords: ovarian cancer; DJ-1; cisplatin; combinatorial therapy; siRNA; IV chemotherapy; intravenous chemotherapy; IP chemotherapy; intraperitoneal chemotherapy; PTEN; phosphatase and tensin homolog; p53; tumor suppressor protein 53; NRF2; nuclear factor (erythroi
Detection and quantification of d-amino acid residues in peptides and proteins using acid hydrolysis
Keywords: NMDA; N-methyl-d-aspartate; DLP-2; defensin-like peptide-2; DAEP; d-aspartyl endopeptidase; 2D-PAGE; two-dimensional polyacrylamide gel electrophoresis; LC-MS/MS; liquid chromatography-tandem mass spectrometry; HPLC; high-performance liquid chromatography
A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer
Keywords: Cytotoxic hybrid molecule; LHRH; Salvage chemotherapy; Targeted therapy; Zoptarelin doxorubicin;
Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth
Keywords: Abu; α-aminobutanoyl; Ada; 12-aminododecanoyl; Agm; agmatine; Aoc; 8-amino octanoyl; Cpa; para-chloro-Phe; Fpa5; pentafluoro-Phe; GH; growth hormone; GHRH; growth hormone releasing hormone; h; human; Har; homoArg; IGF; insulin-like growth factor; LHRH; l
Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy
Keywords: AFM; atomic force microscopy; AMD; age-related macular degeneration; ANG; Angiopep-2; apoB; apolipoprotein B; ATP; adenosine triphosphate; AURKA; Aurora A kinase; BMA; butylmethacrylate; BPEI; branched PEI; BSA; bovine serum albumin; CCP; charge-conversio
Adult-Onset Hypogonadism
Keywords: AD; androgen deficiency; AOH; adult-onset hypogonadism; BACH; Boston Area Community Health; BMI; body mass index; BPH; benign prostatic hypertrophy; CVD; cardiovascular disease; DHT; dihydrotestosterone; DM2; type 2 diabetes; EMAS; European Male Ageing St
A novel synthetic luteinizing hormone-releasing hormone (LHRH) analogue coupled with modified β-cyclodextrin: Insight into its intramolecular interactions
Keywords: BOP; benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate; CLTR-Cl; 2-chlorotrityl chloride; DCC; N,Nâ²-dicyclohexylcarbodiimide; DMA; dimethylacetamide; DIC; N,Nâ²-diisopropylcarbodiimide; DIEA; diisopropylethylamine; DMF; N,N-di
N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy
Keywords: Prostate cancer; Androgen signaling; Taxanes; Therapeutic resistance; Epithelial-mesenchymal transition; ADT; androgen deprivation therapy; AR; androgen receptor; AR-V; androgen receptor splice variant; CRPC; castration-resistant prostate cancer; DHT; dih
The Transport and Efflux of Glycosylated Luteinising Hormone-Releasing Hormone Analogues in Caco-2 Cell Model: Contributions of Glucose Transporters and Efflux Systems
Keywords: LHRH; SGLT1; GLUT2; transport; Caco-2 cell; peptides; MRP2; P-glycoprotein; glycosylation; efflux pumps;
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro
Keywords: DHEA; dehydroepiandrosterone; DHT; dihydrotestosterone; LHRH; luteinizing hormone releasing hormone; LH; luteinizing hormone; AR; androgen receptor; CRPC; castration resistant prostate cancer; PSA; prostate specific antigen; SRD5A1/2; 5-alpha-reductase is
Catecholaminergic system innervates galanin-immunoreactive neurons in the human diencephalon
Keywords: ABC method; avidin-biotin complex; AP; anterior pituitary; AVP; arginine vasopressin; CRH; corticotropin-releasing hormone; DAB; diaminobenzidine; DBH; dopamine-beta-hydroxylase; galanin-IR; galanin-immunoreactive; GHRH; growth hormone-releasing hormone
Gonadotropin releasing hormone (GnRH) and gonadotropin inhibitory hormone (GnIH) in the songbird hippocampus: Regional and sex differences in adult zebra finches
Keywords: Brain; Hypothalamus; LHRH; Memory; RFRP-3; Sex difference; Zebra finch;
Photoperiod-dependent regulation of gonadotropin-releasing hormone 1 messenger ribonucleic acid levels in the songbird brain
Keywords: LHRH; Plasticity; Preoptic area; Photoperiod
Sialorphin and its analog as ligands for copper(II) ions
Keywords: TRH; thyrotropin-releasing hormone; LHRH; luliberin; LH; luteinizing hormone; FSH; follicle-stimulating hormone; Sialorphin; Peptides; Copper(II) ion; Metal ions complexes; Synthesis; Potentiometry; Stability constants; UV-Vis; CD; NMR; Theoretical calc
Androgen Deprivation Therapy Impact on Quality of Life and Cardiovascular Health, Monitoring Therapeutic Replacement
Keywords: Adverse Events; LHRH; GnRH; Antiandrogen; Morbidity
Extended Followup Oncologic Outcome of Randomized Trial Between Cryoablation and External Beam Therapy for Locally Advanced Prostate Cancer (T2c-T3b)
Keywords: prostatic neoplasms; cryosurgery; radiotherapy; bDFS; biochemical disease-free survival; CaP; prostate cancer; CRYO; cryoablation; CT; computerized tomography; DSS; disease specific survival; EBRT; external beam radiotherapy; HT; hormonal therapy; LHRH; l
The in vivo antitumor activity of LHRH targeted methotrexate–human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice
Keywords: Nanoparticles; Methotrexate; Human serum albumin; LHRH; In vivo tumor targeting
Variation in the gonadotrophin-releasing hormone-1 and the song control system in the tropical breeding rufous-collared sparrow (Zonotrichia capensis) is dependent on sex and reproductive state
Keywords: LHRH; GnRH1; Median eminence; Songbird; HPG-axis; HVC
Design, synthesis and evaluation of N-acetyl glucosamine (NAG)-PEG-doxorubicin targeted conjugates for anticancer delivery
Keywords: DOX; doxorubicin; NAG; N-acetyl glucosamine; PEG; polyethylene glycol; DMF; N,N-dimethyl formamide; DCM; dichloromethane; EDC.HCl; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride; DMAP; N,N-diisopropyl-ethylamine,4-(methylamino) pyridine; EPR;
Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: Enhanced enzymatic stability and biological properties
Keywords: Amide linked cyclization; Hormone dependent cancer; Cyclic peptide analogues; Luteinizing hormone-releasing hormone; Medicinal chemistryAcp, aminocaproic acid; Aze, azetidine; BABA, 3-aminobutyric acid; DTT, dithiothreitol; EPI, enhanced product ion; LHRH
Gonadotropin-releasing hormone plasticity: A comparative perspective
Keywords: GnRH1; Reproduction; LHRH; Gonadotropins; Vertebrate; Kisspeptin; LH surge; Feedback;
Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease
Keywords: prostatectomy; brachytherapy; prostatic neoplasms; mortality; risk; AJCC; American Joint Committee on Cancer; AST; androgen suppression therapy; bPFS; biochemical progression-free survival; BT; brachytherapy; EBRT; external beam radiotherapy; LHRH; lutein
An invertebrate [hydroxyproline]-modified neuropeptide: Further evidence for a close evolutionary relationship between insect adipokinetic hormone and mammalian gonadotropin hormone family
Keywords: AKH; adipokinetic hormone; CID; collision-induced dissociation; ESI-MS; electrospray ionization-mass spectrometry; GnRH; gonadotropin-releasing hormone; Hyp; hydroxyproline; LC-MS; liquid chromatography-mass spectrometry; LH; luteinizing hormone; LHRH;
Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence
Keywords: prostate; prostatic neoplasms; prostate-specific antigen; leuprolide; goserelin; ADT; androgen deprivation therapy; CRPC; castrate resistant PC; GA; goserelin acetate; LA; leuprolide acetate; LHRH; luteinizing hormone-releasing hormone; PC; prostate cance
Cognitive, Behavioral, and Systems NeuroscienceResearch PaperIntimate associations between the neuropeptide Y system and the galanin-immunoreactive neurons in the human diencephalon
Keywords: hypothalamus; NPY; galanin; diencephalon; hypothalamo-hypophyseal axis; immunohistochemistry; ACTH; adrenocorticotrope hormone; DAB; diaminobenzidine; LH; luteinizing hormone; LHRH; luteinizing hormone-releasing hormone; MBH; medial basal hypothalamus; NP
Calcium dynamics in gonadotropin-releasing hormone neurons
Keywords: GnRH; LHRH; Calcium; GABA; Glutamate; Electrophysiology; Monkey; Mouse; GT1; Embryo
The TIP39-PTH2 receptor system: Unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms
Keywords: ACTH; adrenocorticotropin; AVP; arginine-vasopressin; CGRP; calcitonin gene-related peptide; CRH; corticotropin releasing hormone; DRG; dorsal root ganglion; ED; embryonic day; GH; growth hormone; i.c.v.; intracerebroventricular; LH; luteinizing hormone;
P2X receptors are expressed on neurons containing luteinizing hormone-releasing hormone in the mouse hypothalamus
Keywords: P2X receptors; ATP; LHRH; Colocalization; Forebrain; Mouse; Hypothalamus;
A large proportion of patients with prostate cancer undergoing androgen deprivation therapy continue to die from non-cancer causes in the PSA era
Keywords: ADT; androgen deprivation therapy; LHRH; luteinizing hormone-releasing hormone; MRC; Medical Research Council; PCa; prostate cancer; PSA; prostate specific antigen; VACURG; Veterans Administration Cooperative Urological Research Group; Androgen antagonist